Cooperative Agreement NU58DP007917
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$460K
Funding Federal Agency
National Center for Chronic Disease Prevention and Health Promotion
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.376
Assistance Type
Cooperative Agreement
Place of Performance
Georgia, USA
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program to the Young Survival Coalition, Inc. The five-year award period runs from September 30, 2024 to September 29, 2029. The program aims to increase support for caregivers and families, raise awareness of clinical trials, and improve quality of life for young breast...
The Centers for Disease Control and Prevention (CDC) awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program. The award, effective from September 30, 2024 to September 29, 2029, is intended to provide comprehensive support for young breast cancer survivors and metastatic breast cancer patients, including increasing support for their caregivers and families, raising...
The federal Cooperative Agreement award NU58DP007916, titled "Bridging Gaps and Transforming Care for Young Breast Cancer Survivors and Those with Metastatic Disease," is funded by the National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention (CDC). The $460,000 award, with a performance period from September 30, 2024 to September 29, 2029, supports Weill Medical College of Cornell University in New York City to...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $460,000 Cooperative Agreement under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program to Force-Facing Our Risk Of Cancer Empowered, Inc. The five-year award period runs from September 30, 2024 to September 29, 2029. The program aims to increase support for caregivers and families, raise awareness of clinical trials, and improve quality of...
The federal Cooperative Agreement award of $1,379,961.00 from the Centers for Disease Control and Prevention (CDC) under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program aims to provide comprehensive support for young breast cancer survivors and metastatic breast cancer patients. The award, with a period of performance from September 30, 2024 to September 29, 2029, will fund the awardee, Living Beyond...
This $459,993 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program aims to provide comprehensive support for young breast cancer survivors and metastatic breast cancer patients. The five-year award to the University of Illinois will fund outreach and education initiatives, expanded access to care, and community-clinical...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" program (CFDA 93.376) provides $433,375.00 to Adelphi University over a 5-year period from September 30, 2024 to September 29, 2029. The funding supports comprehensive support services, education, and interventions to enhance quality of life for young breast cancer survivors and...
The Dana-Farber Cancer Institute, Inc. (DFCI) was awarded a $460,000 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the federal grant program "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376). This five-year award, running from September 30, 2024 to September 29, 2029, aims to increase support for caregivers and families of young breast cancer survivors and metastatic breast cancer...
The federal Cooperative Agreement award NU58DP007915, provided by the Centers for Disease Control and Prevention under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program, is valued at $460,000 and will be active from September 30, 2024 to September 29, 2029. The award aims to increase support for caregivers and families, raise awareness of clinical trials, and improve quality of life for young breast cancer...
The Centers for Disease Control and Prevention (CDC) awarded a 5-year Cooperative Agreement, titled "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376), to the Michigan Department of Health and Human Services. The $920,000 award aims to increase support for caregivers and families, raise awareness of clinical trials, and improve quality of life for young breast cancer survivors and metastatic breast cancer patients...